Metraipolis › archive › dc_459aaf110ede

Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 Pathways — Europe PMC PMID:42371779

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42371779
DOI
10.1002/advs.76352
License (as archived)
solo-consultazione
Archived
2026-10-18T14:58:44.862Z
SHA-256 of the archived text
d7ec837541171b01a4a449d1250125b0500fdeb24a50822c38a5e750ffc56f44
Stable URL of this page
https://metraipolis.com/documento/dc_459aaf110ede

How to cite

Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 Pathways — Europe PMC PMID:42371779 — Europe PMC (en), https://europepmc.org/article/MED/42371779 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_459aaf110ede (Metraipolis archive dc_459aaf110ede, sha256 d7ec837541171b01a4a449d1250125b0500fdeb24a50822c38a5e750ffc56f44)
BibTeX
@misc{dc459aaf110ede,
  title = {Targeting the ATX-LPA Axis Overcomes TKI Resistance and Immunosuppression in Renal Cell Carcinoma via Dual Inhibition of AKT/mTOR and TBK1/IRF3 Pathways — Europe PMC PMID:42371779},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42371779},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_459aaf110ede; sha256 d7ec837541171b01a4a449d1250125b0500fdeb24a50822c38a5e750ffc56f44},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42371779. Agents can read the archived copy with the MCP tool read_document.